Dynavax Technologies Corp
Change company Symbol lookup
Select an option...
DVAX Dynavax Technologies Corp
GOLD Barrick Gold Corp
MSFT Microsoft Corp
XOM Exxon Mobil Corp
CSCO Cisco Systems Inc
MRVL Marvell Technology Group Ltd
DHT DHT Holdings Inc
DLNG-A Dynagas LNG Partners LP
EEX Emerald Holding Inc
APEN Apollo Endosurgery Inc

Health Care : Biotechnology | Small Cap Growth
Company profile

Dynavax Technologies Corporation is a clinical-stage immunotherapy company. The Company is focused on leveraging the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Its product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. Its products include HEPLISAV-B, AZD1419, SD-101, DV281, DV230F and DV1001. HEPLISAV-B is an investigational adult hepatitis B vaccine. AZD1419 is being developed for the treatment of asthma. SD-101 is an investigational TLR9 agonist designed to elicit a potent and focused immune response to cancer. DV281 is an investigational TLR9 agonist designed specifically for focused delivery to primary lung tumors and lung metastases. DV230F is indicated for the treatment of Liver Tumors. DV1001 targets TLR 7 and 8 agonist for multiple malignancies. DV230F and DV1001 are in pre-clinical stage of development.

Day's Change
0.29 (5.65%)
B/A Size
Day's High
Day's Low

Today's volume of 2,872,170 shares is on pace to be much lighter than DVAX's 10-day average volume of 9,144,275 shares.

  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
    1:26p ET 05/26/20
  • Last (size)
  • 52-Wk Range
    1.80 - 7.20
  • (12/16/19 - 03/16/20)
  • 91.4%
  • Market Cap
  • Shares Outstanding
  • -1.73
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.0
  • 63.38
  • (% of float 04/30/20)

Latest News

May 21, 2020
9:00 pm ET
Globe Newswire
4:01 pm ET
Globe Newswire
May 19, 2020
9:31 am ET
PR Newswire
May 12, 2020
8:50 am ET
PR Newswire
May 07, 2020
4:11 pm ET
Globe Newswire
April 28, 2020
4:11 pm ET
Globe Newswire
April 23, 2020
5:02 pm ET
Globe Newswire
April 16, 2020
7:30 am ET
Globe Newswire
April 08, 2020
8:00 am ET
Globe Newswire
April 02, 2020
4:30 pm ET
Globe Newswire
March 26, 2020
11:56 am ET
7:30 am ET
Globe Newswire
March 24, 2020
8:30 am ET
Globe Newswire
8:30 am ET
March 11, 2020
4:10 pm ET
Globe Newswire
2:30 pm ET
March 02, 2020
8:00 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.